Abstract
Troponin is a marker that displays cardiac injury quickly and accurately. In adults, troponin elevation is usually associated with coronary artery disease and requires urgent cardiac catheterization. In healthy children, myocardial injury is rare and may develop due to many different causes. Therefore, troponin elevation in children and adolescents does not usually require emergency cardiac catheterization. The aim of this study is to assess the most common causes of troponin elevation in children and adolescents and to show which diagnostic tests are helpful in assessing pediatric patients with elevated troponin. Patients who had been diagnosed with troponin I elevation (> 0.06 ng/ml) at Dr. Sami Ulus Maternity, Children's Health and Disease Training and Research Hospital between 2007 and 2018 were retrospectively evaluated. Patients undergoing cardiac surgery and those with severe congenital heart disease were excluded from the study. The medical records of the patients were examined and age, gender, diagnostic tests, and diagnosis were evaluated. During the study period, the records of 972 patients were obtained. 213 patients were excluded from the study because of heart surgery, congenital heart disease, and neonatal asphyxia or sepsis. Of the remaining 759 patients, 58% were male, 42% were female, and the median age was 4 years (3 days to 17 years). The most frequent causes are myopericarditis (n: 164), drug intoxications (n: 85), carbon monoxide poisoning (n: 74), perimyocarditis (n: 65), and intensive inhalation β agonist use in acute asthma and lower respiratory tract infections (n: 70). Patients diagnosed with myocarditis and myopericarditis were admitted with a complaint of chest pain, and the diagnosis was made by history, physical examination, ECG, and echocardiographic findings. Unlike adults, troponin I elevation may be associated with many cardiac and non-cardiac pathologies in children. The most common pathologies in cardiac etiology are myopericarditis and perimyocarditis and can be diagnosed by history, physical examination, ECG, and echocardiography. Cardiac catheterization is not necessary except for rare cardiac pathologies and does not alter the prognosis.
Similar content being viewed by others
References
Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E (1996) Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. New Engl J Med 335(18):1342–1349. https://doi.org/10.1056/nejm199610313351802
Thankavel PP, Mir A, Ramaciotti C (2013) Elevated troponin levels in previously healthy children: value of diagnostic modalities and the importance of a drug screen. Cardiol Young 24(02):283–289. https://doi.org/10.1017/s1047951113000231
Kanaan UB, Chiang VW (2004) Cardiac troponins in pediatrics. Pediatr Emerg Care 20(5):323–329. https://doi.org/10.1097/01.pec.0000125664.35690.51
Kane DA, Fulton DR, Saleeb S, Zhou J, Lock JE, Geggel RL (2010) Needles in hay: chest pain as the presenting symptom in children with serious underlying cardiac pathology. Congenit Heart Dis 5:366–373. https://doi.org/10.1111/j.1747-0803.2010.00436.x
Eerola A, Poutanen T, Savukoski T, Pettersson K, Sairanen H, Jokinen E, Pihkala J (2014) Cardiac troponin I, cardiac troponin specific autoantibodies and natriuretic peptides in children with hypoplastic left heart syndrome. Interact CardioVasc Thorac Surg 18(1):80–85. https://doi.org/10.1093/icvts/ivt430
Friedman KG, Kane DA, Rathod RH, Renaud A, Farias M, Geggel R, Fulton DR, Lock JE, Saleeb SF (2011) Management of pediatric chest pain using a standardized assessment and management plan. Pediatrics 128:239–245. https://doi.org/10.1542/peds.2011-0141
Kern J, Modi R, Atalay MK, Kochilas LK (2009) Clinical myocarditis masquerading as acute coronary syndrome. J Pediatr 154(4):612–615. https://doi.org/10.1016/j.jpeds.2008.10.018
Freedman SB, Haladyn JK, Floh A, Kirsh JA, Taylor G, Thull-Freedman J (2007) Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation. Pediatrics 120(6):1278–1285. https://doi.org/10.1542/peds.2007-1073
Harris TH, Gossett JG (2016) Diagnosis and diagnostic modalities in pediatric patients with elevated troponin. Pediatr Cardiol. https://doi.org/10.1007/s00246-016-1459-7
Imazio M, Trinchero R (2008) Myopericarditis: etiology, management, and prognosis. Int J Cardiol 127(1):17–26. https://doi.org/10.1016/j.ijcard.2007.10.053
Farzad A, Schussler JM (2018) Acute myopericardial syndromes. Cardiol Clin 36:103–114. https://doi.org/10.1016/j.ccl.2017.09.004
Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J et al (2015) 2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36(42):2921–2964. https://doi.org/10.1093/eurheartj/ehv318
Wang K, Asinger RW, Marriott HJL (2003) ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 349(22):2128–2135. https://doi.org/10.1056/nejmra022580
Brady WJ, Syverud SA, Beagle C, Perron AD, Ullman EA, Holstege C, Riviello RJ, Ripley A, Ghaemmaghami CA (2001) Electrocardiographic ST-segment elevation: the diagnosis of acute myocardial infarction by morphologic analysis of the ST segment. Acad Emerg Med 8(10):961–967. https://doi.org/10.1111/j.1553-2712.2001.tb01094.x
Bischof JE, Worrall C, Thompson P, Marti D, Smith SW (2016) ST depression in lead aVL differentiates inferior ST-elevation myocardial infarction from pericarditis. Am J Emerg Med 34(2):149–154. https://doi.org/10.1016/j.ajem.2015.09.035
O'Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL, Larson SM, Epstein SE (1987) Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 76:1214–1223. https://doi.org/10.1161/01.cir.76.6.1214
Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8:545–557. https://doi.org/10.1016/s0735-1097(86)80181-4
Tanaka M, Fujiwara H, Onodera T, Wu DJ, Matsuda M, Hamashima Y, Kawai C (1987) Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 75:1130–1139. https://doi.org/10.1161/01.cir.75.6.1130
Hessel MH, Atsma DE, van der Valk EJ, Bax WH, Schalij MJ, van der Laarse A (2008) Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch 455:979–986. https://doi.org/10.1007/s00424-007-0354-8
Yedder NB, Roux JF, Paredes FA (2011) Troponin elevation in supraventricular tachycardia: primary dependence on heart rate. Can J Cardiol 27:105–109. https://doi.org/10.1016/j.cjca.2010.12.004
Omaye ST (2002) Metabolic modulation of carbon monoxide toxicity. Toxicology 180(2):139–150. https://doi.org/10.1016/s0300-483x(02)00387-6
Thom SR, Fisher D, Xu YA, Notarfrancesco K, Ischiropoulos H (2000) Adaptive responses and apoptosis in endothelial cells exposed to carbon monoxide. Proc Natl Acad Sci USA 97(3):1305–1310. https://doi.org/10.1073/pnas.97.3.1305
Kogaki S (2011) Highly sensitive cardiac troponin-I in congenital heart disease. Circ J 75(9):2056–2057. https://doi.org/10.1253/circj.cj-11-0772
Suleiman MS, Lucchetti V, Caputo M, Angelini GD (1999) Short periods of regional ischaemia and reperfusion provoke release of troponin I from the human hearts. Clin Chim Acta 284(1):25–30. https://doi.org/10.1016/s0009-8981(99)00056-x
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Tamer Yoldaş and Utku Arman Örün declare that they have no conflict of interest.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yoldaş, T., Örün, U.A. What is the Significance of Elevated Troponin I in Children and Adolescents? A Diagnostic Approach. Pediatr Cardiol 40, 1638–1644 (2019). https://doi.org/10.1007/s00246-019-02198-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-019-02198-w